HEALTHCARE MARKETSUNH 345.80 +4.64%ELV 405.30 +3.88%CI 279.14 +2.23%CVS 82.01 +2.46%HUM 400.40 +5.37%CNC 65.22 -0.55%MOH 203.13 -0.10%HCA 474.10 +2.99%THC 263.75 +0.06%UHS 180.10 +2.93%LLY 1357.13 +0.44%PFE 27.64 +0.34%JNJ 271.20 +1.52%MRK 135.06 +1.69%ABBV 288.74 +1.83%NVO 38.55 -0.84%MDT 101.50 +0.88%ABT 104.33 +0.45%ISRG 406.20 -0.26%XLV 179.05 +0.90%Delayed quotes. Not investment advice.
FRIDAY, NOVEMBER 20, 2026
EDITION:
Morning Briefing   Help
HLA Network News
Everything about your health. Local, state, national, federal.
Providers & Industry · Atlanta

FDA approves first drug for rare genetic brain disorder

Infilbray targets type 3 Gaucher disease, a genetic condition that damages the nervous system and causes balance and memory problems.

The U.S. Food and Drug Administration has approved Infilbray (venglustat), the first drug to treat neurological symptoms of type 3 Gaucher disease, according to FOX 5 Atlanta. The drug is approved for patients weighing at least 15 kilograms, or about 33 pounds.

Type 3 Gaucher disease is a rare inherited condition where the body cannot break down fatty substances properly because of a faulty enzyme. These substances build up in organs, tissues, and the brain, causing serious health problems over time. Unlike type 1 Gaucher disease, type 3 affects the brain and nervous system, leading to difficulties with balance, coordination, speech, memory, and thinking that can worsen over time.

Infilbray works by reducing the buildup of harmful substances throughout the body and in the brain. According to the FDA, the drug's ability to reach the brain means it can address the root cause of neurological symptoms. The Acting FDA Commissioner said the approval brings an important new treatment option to patients and their healthcare providers.

What you can do: Remove 'affecting children' from headline—sources do not establish this as a pediatric disorder. The 15 kg weight threshold is a dosing parameter, not an age indicator.

Sources

Not medical advice. HLA Network News reports health news. Talk to your doctor or care team about your own care. In a crisis, call or text 988. In an emergency, call 911.
ADVERTISEMENT · SIDEBAR 300x250
Reach health readers here. Advertise with HLA